A CRO, or contract research organization, is a company that provides, on a contractual basis, services in the biomedical research field. Given their crucial role in the development of new treatments and technologies, as well as their economic importance, BIOQuébec and CATALIS, with financial support from the Ministry of Economy and Innovation, conducted a study of Quebec CROs to chart the sector’s impact and measure its growth, strengths, and needs.

studyreportGuest UserMay 9, 2023BIOOQuébecinnovation, study report, biopharmaceutical

A Framework for Action to Support Quebec’s Biopharmaceutical Innovations and Bolster Quebec’s Autonomy

BIOQuébec commissioned The JBL Group to produce a comprehensive account of the situation by first, rigorously documenting the Quebec healthcare system’s recommendation process for Quebec-based innovations and secondly, to develop, with industry partners, public policy proposals that would support the Quebec biopharmaceutical industry’s innovations and development. BIOQuébec’s review was prompted by a widespread perception among many members that Quebec-based drugs and biopharmaceutical industry products were unfavourably considered by the Quebec health and social services network.

studyreportGuest UserMay 24, 2022BIOOQuébecinnovation, study report, biopharmaceutical

Study on Public Policies and Financing

The biotechnology and CRO industry issues 17 financing and public policy.

studyreportGuest UserNovember 14, 2019Public policies, Financing, study, study report

CROs in Québec

Their concentration, the nature of their involvement in research, and their economic power confirm that Québec’s CROs are a key element in the life sciences innovation chain.

studyreportCatherine LamontagneApril 3, 2017CROS, study report, socio-economic, development, province

Biotechs in Québec

Biotechs base themselves on everyday life to find innovative solutions to various challenges to human health and well-being through the use of cutting-edge technology.